The 6 February 2026 executive order reducing US tariffs on Indian goods from 25 percent to 18 percent has reset India's largest export corridor for the first time since 2023. The White House announcement also removes a separate 25 percent ad valorem band linked to Russian oil trade, clearing regulatory uncertainty that had constrained Indian exporters across multiple sectors.

Goldman Sachs now projects India's real GDP growth at 6.9 percent for 2026 and 6.8 percent for 2027, above consensus estimates. The IMF's April 2026 World Economic Outlook positions India at 6.5 percent growth — the highest among major economies.

The Export Window Opens

Indian exporters in textiles, pharmaceuticals, auto-components, and electronics face a seven percentage-point tariff advantage compared to the 2023-2026 period. This translates directly into price competitiveness in the US market, where Indian goods had been competing at a disadvantage for three years. The removal of the Russian oil-related tariff band eliminates regulatory complexity that had made compliance planning difficult for exporters across multiple product categories.

The tariff reduction coincides with expanded Indian manufacturing capacity. The PLI schemes in electronics and pharmaceuticals have built export-ready production bases positioned to capitalise on improved market access. Auto-component manufacturers, who maintained US client relationships despite tariff headwinds, can recapture market share lost to competitors from Vietnam and Mexico.

From Tariff Truce to Market Access

The 20-22 April trade talks in Washington, led by Additional Secretary for Commerce Darpan Jain, will determine whether temporary tariff relief becomes permanent market access. The Federal reports that negotiators are rethinking the broader bilateral trade agreement framework, with the tariff changes forcing a fundamental reassessment of market-access rules.

The talks will cover services trade, digital commerce, pharmaceutical regulations, and export-control carve-outs on strategic technologies. For Indian IT services companies, digital trade provisions could standardise cross-border data flows and professional licensing recognition. Pharmaceutical exporters seek regulatory harmonisation that would reduce the compliance burden for generic drug approvals in the US market.

Strategic technology export controls present both opportunity and constraint. Indian companies in semiconductors, telecommunications equipment, and advanced materials want carve-outs from broad-based export restrictions. The US position balances commercial access with national security considerations, creating a negotiation dynamic where Indian technological capabilities become the metric for graduated market access.

The Competitiveness Test

The tariff cut provides short-term export competitiveness, but Indian exporters face a structural test: converting tariff room into market share before the next US administration potentially revisits the deal. This requires moving beyond price competition to product differentiation, supply-chain integration, and customer relationship building.

Textile exporters, who bore the heaviest burden during the 2023-2026 tariff period, must compete on design capabilities and faster turnaround times. Electronics manufacturers need to demonstrate scale and reliability that justifies long-term sourcing commitments from US buyers. Pharmaceutical companies have the opportunity to expand beyond generic drugs into specialty medications and biosimilars.

The timing creates urgency. Export companies that establish market position and customer relationships during the 18-month tariff relief window will be better positioned to retain market share even if tariff rates change again. The current period is less about maximising short-term export volumes and more about building sustainable competitive advantages.

Reading the Economic Momentum

Goldman Sachs's above-consensus growth projections reflect how trade normalisation affects broader economic confidence. Export earnings support the rupee, provide foreign exchange stability, and create employment in manufacturing regions. The tariff cut also signals to foreign investors that India-US commercial relationships have stabilised, potentially attracting FDI in export-oriented sectors.

The growth impact extends beyond direct exports. Auto-component manufacturers who regain US market share will invest in capacity expansion, creating supplier ecosystem jobs. IT services companies with improved digital trade access will hire additional engineers and expand offshore development centres. Pharmaceutical companies facing reduced regulatory barriers will increase R&D spending on products tailored for US market requirements.

The February tariff reset is the first major recalibration of India's largest bilateral trade relationship since 2023. Indian exporters have an 18-month window to prove that tariff relief can translate into lasting market position. The April trade talks will determine whether temporary competitive advantage becomes permanent commercial architecture. For an economy targeting developed-nation status by 2047, the ability to sustain and expand export market share in the world's largest consumer market remains a critical test of manufacturing competitiveness and commercial diplomacy.